CCO Oncology Podcast

189 Folgen

1. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom

   Vom: 20.11.2020
2. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France

   Vom: 19.11.2020
3. Molecular Classification of Endometrial Carcinoma in the Clinic Today

   Vom: 11.11.2020
4. Advances in Immunotherapy for Endometrial Cancer

   Vom: 11.11.2020
5. Developments in Acute Leukemias: Expert Answers to Clinician Questions

   Vom: 2.10.2020
6. Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy

   Vom: 2.10.2020
7. Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond

   Vom: 2.10.2020
8. Experts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC

   Vom: 21.9.2020
9. The Art of Medicine: Clinical Considerations for Patients With Advanced RCC

   Vom: 21.9.2020
10. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1

    Vom: 17.9.2020
11. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3

    Vom: 17.9.2020
12. Clinical Considerations for <em>RET</em> Fusion–Positive NSCLC

    Vom: 17.9.2020
13. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2

    Vom: 16.9.2020
14. CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

    Vom: 14.9.2020
15. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond

    Vom: 8.9.2020
16. FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma

    Vom: 3.9.2020
17. New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments

    Vom: 1.9.2020
18. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy

    Vom: 31.8.2020
19. Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma

    Vom: 31.8.2020
20. MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1

    Vom: 28.8.2020